International backing of about $4.5 million will enable the formation of the Alliance for Accelerating Excellence in Science in Africa (AESA), planned for June. The Alliance will direct African science programs and manage research focusing on the continent. Much of the research funding in Africa is from international funders, which determine how it is spent. […]

The US FDA has finalized its 2012 drafts on biosimilarity with three guidance documents. The first guidance presents the approach for sponsors to obtain evidence showing biosimilarity and by the FDA in reviewing applications for biosimilars. It also provides some clarifications in its recommendations. It encourages frequent consultation with the FDA during the early stages […]

More than 60 authors from the academic and industrial sectors have published a science and technology road map in the journal Nanoscale for graphene, related to 2-D crystals, other 2-D materials and hybrids. The authors are members of the Graphene Flagship, an international research initiative formed to take graphene from labs and into European society […]

In this article, IBO updates the patent litigation landscape for the analytical instrument and lab product industry. New Development In March, the US Court of Appeals for the Federal Circuit reversed in part and vacated in part the judgment in favor of Enzo Biochem and Yale University in their patent infringement suit against Life Technologies […]

Orpington, UK 4/21/15; London, UK 4/22/15—Private equity firm Foresight and company management have acquired Specac, a supplier of spectroscopic accessories, from Smiths for £2.8 million ($4.2 million = £0.67 = $1). Specac revenues have grown 35% in the last four years, with 80% of sales outside the UK. Products include the Quest ATR diamond and […]

Pittsburgh, PA 4/15/15—Cianflone Scientific Instruments, a manufacturer of lab and portable x-ray spectrometry instruments for on-site chemical analysis and coating thickness measurements, has been acquired by Main Line Equity Partners. The purchase price was not disclosed. “This acquisition presents an opportunity for us to help Cianflone further capitalize on existing business today, while also serving […]

Germantown, MD and Hilden, Germany 3/16/15; Cambridge, MA 3/16/15—QIAGEN has acquired certain technology and other assets from AdnaGen, a subsidiary of Alere, including the CE-IVD marked products AdnaTest Breast Cancer and AdnaTest Prostate Cancer. Terms were not disclosed. The technology enables enrichment and molecular analysis of circulating tumor cells from blood samples. QIAGEN will exclusively […]